Lab Reagents

All Competitors Laboratories manufactures the ci darlaiani reagents distributed by Genprice. The Ci Darlaiani reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact All Competitors. Other Ci products are available in stock. Specificity: Ci Category: Darlaiani

Serum / Plasma information

CI-949
HY-U00364	MedChemExpress	5mg	EUR 4513

CI-994
1742-10	Biovision		EUR 137

CI-994
1742-100	Biovision		Ask for price

CI-994
1742-50	Biovision		EUR 387

CI 966 hydrochloride
B6677-10	ApexBio	10 mg	EUR 366

CI 966 hydrochloride
B6677-50	ApexBio	50 mg	EUR 1379

CI 898 trihydrochloride
B6934-10	ApexBio	10 mg	EUR 286

CI-1033 (Canertinib)
E1KS1019	EnoGene	25mg	EUR 247

CI-1040 (PD184352)
E1KS1020	EnoGene	5mg	EUR 325

PD184352 (CI-1040)
A1792-100	ApexBio	100 mg	EUR 595
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

PD184352 (CI-1040)
A1792-25	ApexBio	25 mg	EUR 258
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

PD184352 (CI-1040)
A1792-5	ApexBio	5 mg	EUR 108
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

PD184352 (CI-1040)
A1792-5.1	ApexBio	10 mM (in 1mL DMSO)	EUR 113
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

Canertinib (CI-1033)
A1845-10	ApexBio	10 mg	EUR 108
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.

Canertinib (CI-1033)
A1845-100	ApexBio	100 mg	EUR 189
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.

Canertinib (CI-1033)
A1845-5.1	ApexBio	10 mM (in 1mL DMSO)	EUR 108
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.

Canertinib (CI-1033)
A1845-50	ApexBio	50 mg	EUR 148
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.